Hydrophobic Tubes for Lymphedema

Sponsor
Universidade do Porto (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05970068
Collaborator
(none)
20
1
2
39
0.5

Study Details

Study Description

Brief Summary

Lymphedema is a chronic condition causing fluid buildup in affected limbs. Traditional treatments often fall short, but subcutaneous implantation of hydrophobic silicone tubes shows promise, creating artificial drainage pathways. This approach proved effective in managing obstructive lymphedema in lower limbs. Further research is needed to validate its efficacy and explore long-term outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: implantation of hydrophobic tubes for edema fluid drainage
  • Device: Best Medical Treatment
N/A

Detailed Description

Lymphedema is a chronic condition that affects the lymphatic system and accumulates protein-rich fluid in the interstitial spaces of the affected limb. The condition can occur after surgery, trauma, radiation therapy, or infection and can cause significant physical, functional, and psychosocial impairment. The chronic swelling and fibrosis of the affected limb can lead to difficulty with daily activities, decreased mobility, reduced quality of life, and increased susceptibility to infections (1).

Currently, the management of lymphedema involves both conservative and surgical approaches. Conservative treatment includes complex decongestive therapy, which combines manual lymphatic drainage, compression therapy, exercise, and skincare (reference here). While this approach can be effective, it requires long-term commitment and compliance from patients, which can be challenging (reference here). Surgical approaches, such as lymphaticovenular anastomosis or vascularized lymph node transfer, are reserved for patients with mild to severe or refractory lymphedema with moderate results (2).

Liposuction has been used as a treatment for lower limb lymphedema. The traditional treatment of lymphedema includes compression garments, exercise, and manual lymphatic drainage, but these methods are not very effective.

In advanced cases of lymphedema, where all main lymphatics vessels are obstructed, one possible solution may be to create artificial pathways for edema fluid to flow away from the obstructed regions. This can be achieved through the subcutaneous implantation of silicone tubes, a novel method for draining edema fluid in obstructive lymphedema of limbs (3).

In the lower limbs, the tubes are placed from the leg to the lumbar or hypogastric region, creating channels for fluid to flow away from the obstructed areas to the non-obstructed regions, where absorption can take place.

The subcutaneous implantation of hydrophobic tubes is a minimally invasive procedure that has shown promising results in the management of obstructive lymphedema of the lower limbs.

In a group of 20 patients with obstructive lymphedema of the lower limbs that developed after lymphadenectomy and irradiation of the pelvis because of uterine cancer, this procedure was found to be effective after unsuccessful conservative therapy. The patients underwent the implantation of hydrophobic silicone tubes, followed by external compression using intermittent pneumatic compression and elastic support of tissues (3).

Overall, the implantation of hydrophobic tubes presents a promising alternative for managing obstructive lymphedema of the lower limbs. It has the potential to improve the quality of life for those who suffer from this condition, especially in advanced cases where other treatment options have failed. Further research is necessary to validate the efficacy of this approach and its long-term outcomes as well as to develop new bioengineered tubes for the drainage of lymphedematous extremities.

  1. Vaillant L, Tauveron V. [Primary lymphedema of limbs]. Presse Med. 2010;39(12):1279-86.

  2. Lee JW, Lee TY, Moon KC, You HJ, Kim DW. Lymphatic complex transfer as combined lymph vessel and node transfer for advanced stage upper extremity lymphedema. J Vasc Surg Venous Lymphat Disord. 2023.

  3. Olszewski WL, Zaleska M. A novel method of edema fluid drainage in obstructive lymphedema of limbs by implantation of hydrophobic silicone tubes. J Vasc Surg Venous Lymphat Disord. 2015;3(4):401-8.

  4. Kwon HR, Hwang JH, Mun GH, Hyun SH, Moon SH, Lee KH, et al. Predictive role of lymphoscintigraphy undergoing lymphovenous anastomosis in patients with lower extremity lymphedema: a preliminary study. BMC Med Imaging. 2021;21(1):188.

  5. Nuri T, Iwanaga H, Otsuki Y, Ueda K. Lymphoscintigraphy for prediction of effect of lymphaticovenular anastomosis for treatment of secondary lower limb lymphedema. J Vasc Surg Venous Lymphat Disord. 2022;10(5):1079-86 e2.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Once eligible patients have been identified, they would be randomized into one of two groups - the intervention group or the control group. Randomization will help ensure that the two groups are comparable in terms of baseline characteristics, which can minimize the risk of bias in the study. The program used will be https://www.random.org/lists/. Group 1: Surgery + best medical treatment The intervention group would receive the novel treatment of implantation of hydrophobic tubes for edema fluid drainage, in addition to the best medical treatment available. Group 2: best medical treatment This control group would receive only the best medical treatment available.Once eligible patients have been identified, they would be randomized into one of two groups - the intervention group or the control group. Randomization will help ensure that the two groups are comparable in terms of baseline characteristics, which can minimize the risk of bias in the study. The program used will be https://www.random.org/lists/. Group 1: Surgery + best medical treatment The intervention group would receive the novel treatment of implantation of hydrophobic tubes for edema fluid drainage, in addition to the best medical treatment available. Group 2: best medical treatment This control group would receive only the best medical treatment available.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Implantation of Hydrophobic Tubes for Edema Fluid Drainage in Obstructive Lymphedema of Limbs - a Randomized Clinical Trial
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1: Surgery + best medical treatment

The intervention group would receive the novel treatment of implantation of hydrophobic tubes for edema fluid drainage and the best medical treatment available.

Procedure: implantation of hydrophobic tubes for edema fluid drainage
1 - A 2-cm-long incision is made at the border of the hypogastrium or lumbar region 10 cm above the inguinal crease; 2- A 1.5-cm-wide and 100-cm-long metal tube tunneling device is introduced under the skin and bluntly passed in the subcutaneous tissue toward the thigh and internal aspect of the calf; 3- Incisions 2 cm long are made in the groin and calf, through which the tunneling device was passed; 4-The hydrophobic tube is passed upward through the tunneling device, after which the tunneling device is removed; 5-The upper and lower ends of the hydrophobic tubes are fixed to the fascia with absorbable sutures.

Device: Best Medical Treatment
Compressive therapy, Phisioterapy, venous intervention

Active Comparator: Group 2: best medical treatment

This control group would receive only the best medical treatment available.

Device: Best Medical Treatment
Compressive therapy, Phisioterapy, venous intervention

Outcome Measures

Primary Outcome Measures

  1. Lower limb circumference in cm [Preoperative, six months, one year, second year]

    Lower limb circumference in cm - ankle, calf 15 cm below the knee; knee; thigh 15 cm above the knee

Secondary Outcome Measures

  1. PROMS - Lymphedema quality of life [preoperative, six months, one year, two years]

    diseae specific qol questionnaire

  2. PROMS - SF 36 [preoperative, six months, one year, two years]

    Qol questionnaire

  3. Lymphoscintigraphy [preoperative, one year (only in the intervention group)]

    diagnostic exam

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Lower limb lymphedema (Grade II-IV)

  • Total occlusion at lymphoscintigraphy

  • Patients treated at Centro Hospitalar Universitário de São João by the same surgical team

  • Age >18 years old;

  • Lymphedema praecox

  • Lower limb perimeter >15% superior to contralateral limb

Exclusion Criteria:
  • Secondary lymphedema

  • Congenital lymphedema (Milroy, Meige, Klinefelter, Noonan, and Turner syndromes)

  • Acute infection of the limb

  • Chronic venous insufficiency

  • Neoplasic disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculdade de Medicina da Universidade do Porto Porto Portugal 4200-319

Sponsors and Collaborators

  • Universidade do Porto

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
João Rocha Neves, MD, MPH, PHD, FEBVS, Universidade do Porto
ClinicalTrials.gov Identifier:
NCT05970068
Other Study ID Numbers:
  • 300-23
First Posted:
Aug 1, 2023
Last Update Posted:
Aug 1, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by João Rocha Neves, MD, MPH, PHD, FEBVS, Universidade do Porto
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 1, 2023